[Consensus statement regarding indications for Leiden (FVL-factor V Leiden) mutation determination when recommending combined hormonal contraception or hormone replacement therapy].
- Gynekologicko-porodnická klinika 1. lékarské fakulty UK a VFN, Praha.
Keywords: Contraceptives, Oral, Hormonal; Contraindications; Estrogen Replacement Therapy; Factor V, genetics, ; Female; Humans; Point Mutation; Thromboembolism, genetics,
Published: June 1, 2003 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |